Kwok Pang is the Chief Operating officer for Autolomous, a software and technology platform for CGT manufacturing. Autolomous’ platform, AutoloMATE is a business-critical robust digital solution increasing efficiency, scalability and process streamlining of the GMP manufacturing and product release of cell and gene therapies. These solutions utilize emerging technologies such as Ledger technology and Internet of Things (IoT) to ensure compliance with current and future regulatory requirements. Autolomous enables manufacturers to reduce costs and deliver cell and gene therapies to more patients.
Prior to Autolomous, Kwok was part of the Cell & Gene Therapy Catapult (CGT) manufacturing centre team that established the multi- user, multi-product GMP manufacturing facility. Between 2002- 2017, he held roles at GSK's Cell & Gene Therapy team and the Royal Free London NHS Trust's Centre for Cell, Gene, Tissue Therapies (CCGTT). He has a wealth of experience in CGT manufacturing, digitisation of CGT manufacturing processes and building collaboration within the CGT ecosystem.
Prior to Autolomous, Kwok was part of the Cell & Gene Therapy Catapult (CGT) manufacturing centre team that established the multi- user, multi-product GMP manufacturing facility. Between 2002- 2017, he held roles at GSK's Cell & Gene Therapy team and the Royal Free London NHS Trust's Centre for Cell, Gene, Tissue Therapies (CCGTT). He has a wealth of experience in CGT manufacturing, digitisation of CGT manufacturing processes and building collaboration within the CGT ecosystem.